Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Adverum Biotechnologies Inc (ADVM)

Adverum Biotechnologies Inc (ADVM)
2.80 x 2 3.10 x 1
Post-market by (Cboe BZX)
2.91 -0.06 (-2.02%) 04/25/25 [NASDAQ]
2.80 x 2 3.10 x 1
Post-market 2.91 unch (unch) 16:01 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
2.81
Day High
3.01
Open 2.93
Previous Close 2.97 2.97
Volume 1,037,500 1,037,500
Avg Vol 289,350 289,350
Stochastic %K 15.29% 15.29%
Weighted Alpha -72.58 -72.58
5-Day Change -0.02 (-0.68%) -0.02 (-0.68%)
52-Week Range 2.71 - 10.98 2.71 - 10.98
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 60,793
  • Shares Outstanding, K 20,891
  • Annual Sales, $ 1,000 K
  • Annual Income, $ -130,930 K
  • EBIT $ -103 M
  • EBITDA $ -101 M
  • 60-Month Beta 1.10
  • Price/Sales 62.05
  • Price/Cash Flow N/A
  • Price/Book 0.87

Options Overview Details

View History
  • Implied Volatility 142.56% ( +3.97%)
  • Historical Volatility 97.65%
  • IV Percentile 78%
  • IV Rank 22.08%
  • IV High 607.08% on 04/22/25
  • IV Low 10.92% on 06/14/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 24
  • Volume Avg (30-Day) 88
  • Put/Call OI Ratio 0.64
  • Today's Open Interest 1,463
  • Open Int (30-Day) 1,380

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -1.92
  • Number of Estimates 3
  • High Estimate -1.77
  • Low Estimate -2.01
  • Prior Year -1.50
  • Growth Rate Est. (year over year) -28.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.71 +7.18%
on 04/21/25
Period Open: 4.93
5.23 -44.36%
on 03/27/25
-2.02 (-40.97%)
since 03/25/25
3-Month
2.71 +7.18%
on 04/21/25
Period Open: 4.49
5.72 -49.16%
on 03/21/25
-1.58 (-35.19%)
since 01/24/25
52-Week
2.71 +7.18%
on 04/21/25
Period Open: 9.39
10.98 -73.50%
on 04/30/24
-6.48 (-69.01%)
since 04/25/24

Most Recent Stories

More News
Adverum Biotechnologies: Q4 Earnings Snapshot

Adverum Biotechnologies: Q4 Earnings Snapshot

ADVM : 2.91 (-2.02%)
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones

ADVM : 2.91 (-2.02%)
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ADVM : 2.91 (-2.02%)
Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Conference

ADVM : 2.91 (-2.02%)
Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD

ADVM : 2.91 (-2.02%)
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ADVM : 2.91 (-2.02%)
Adverum Biotechnologies to Participate in the Cowen 45th Annual Health Care Conference

ADVM : 2.91 (-2.02%)
Adverum Biotechnologies to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

ADVM : 2.91 (-2.02%)
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ADVM : 2.91 (-2.02%)
Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ADVM : 2.91 (-2.02%)

Business Summary

Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Adverum develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum's core capabilities include clinical development,...

See More

Key Turning Points

3rd Resistance Point 3.21
2nd Resistance Point 3.11
1st Resistance Point 3.01
Last Price 2.91
1st Support Level 2.81
2nd Support Level 2.71
3rd Support Level 2.61

See More

52-Week High 10.98
Fibonacci 61.8% 7.82
Fibonacci 50% 6.85
Fibonacci 38.2% 5.87
Last Price 2.91
52-Week Low 2.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective